Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06454682
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-03
Brief Title:
An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis ALS
Sponsor:
Rejukon Biopharm Inc
Organization:
Rejukon Biopharm Inc
Organization Data
Organization:
Rejukon Biopharm Inc
Class:
INDUSTRY
Study ID:
RJK-002-I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rejukon Biopharm Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None